← Open Payments lookup

OLUFISAYO OMOBO: Open Payments

NPI 1962284471 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$892 in 9 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $265 · 2025 $892

Food & beverage: $892
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.3$321
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$226
Neurocrine BioSciences, Inc.1$140
Supernus Pharmaceuticals, Inc.1$114
E.R. Squibb & Sons, L.L.C.1$76
Lundbeck LLC1$15

Products named: ABILIFY MAINTENA, CAPLYTA, INGREZZA, Qelbree, COBENFY, ABILIFY ASIMTUFII.

Industry payments across DC — which companies pay providers there.